63178-61-0
63178-61-0结构式
- 常用中文名：4-(4-硝基苯基)-1-甲基磺酰基哌嗪
- 常用英文名：1-methylsulfonyl-4-(4-nitrophenyl)piperazine
- CAS号：63178-61-0
- 分子式：C11H15N3O4S
- 分子量：285.32000
- 发布时间：2018-08-01 21:36:34
- 更新时间：2024-01-08 18:57:17
| 中文名 | 4-(4-硝基苯基)-1-甲基磺酰基哌嗪 |
|---|---|
| 英文名 | 1-methylsulfonyl-4-(4-nitrophenyl)piperazine |
| 分子式 | C11H15N3O4S |
|---|---|
| 分子量 | 285.32000 |
| 精确质量 | 285.07800 |
| PSA | 94.82000 |
| LogP | 2.28330 |
| 海关编码 | 2933599090 |
|---|
|
~79%
63178-61-0 |
| 文献：AURIGENE DISCOVERY TECHNOLOGIES LIMITED; SENGUPTA, Saumitra; RAJAGOPALAN, Srinivasan; BELAVAGI, Ningaraddi; RAMACHANDRA, Muralidhara Patent: WO2012/59932 A1, 2012 ; Location in patent: Page/Page column 118 ; WO 2012/059932 A1 |
|
~%
63178-61-0 |
| 文献：Chapdelaine, Marc; Davenport, Timothy; Haeberlein, Markus; Horchler, Carey; McCauley, John; Pierson, Edward; Sohn, Daniel Patent: US2004/87575 A1, 2004 ; US 20040087575 A1 |
|
~%
63178-61-0 |
| 文献：AURIGENE DISCOVERY TECHNOLOGIES LIMITED; SENGUPTA, Saumitra; RAJAGOPALAN, Srinivasan; BELAVAGI, Ningaraddi; RAMACHANDRA, Muralidhara Patent: WO2012/59932 A1, 2012 ; WO 2012/059932 A1 |
|
~%
63178-61-0 |
| 文献：AURIGENE DISCOVERY TECHNOLOGIES LIMITED; SENGUPTA, Saumitra; RAJAGOPALAN, Srinivasan; BELAVAGI, Ningaraddi; RAMACHANDRA, Muralidhara Patent: WO2012/59932 A1, 2012 ; WO 2012/059932 A1 |
|
~%
63178-61-0 |
| 文献：Wang, Shudong; Midgley, Carol A.; Scaerou, Frederic; Grabarek, Joanna B.; Griffiths, Gary; Jackson, Wayne; Kontopidis, George; McClue, Steven J.; McInnes, Campbell; Meades, Christopher; Mezna, Mokdad; Plater, Andy; Stuart, Iain; Thomas, Mark P.; Wood, Gavin; Clarke, Rosemary G.; Blake, David G.; Zheleva, Daniella I.; Lane, David P.; Jackson, Robert C.; Glover, David M.; Fischer, Peter M. Journal of Medicinal Chemistry, 2010 , vol. 53, # 11 p. 4367 - 4378 |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |